基本信息
views: 209
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Pezzuto was the 2014 recipient of the Volwiler Research Award, the top research award from the American Association of Colleges of Pharmacy. He was elected as a Fellow of the American Association for the Advancement of Science.
He is an author of over 600 publications, including the first report describing the cancer preventive activity of resveratrol, a component of grapes and grape products such as red wine. This single manuscript has been cited over 5,000 times, and resveratrol is now in numerous clinical trials and the subject of over 20,000 manuscripts.
Pezzuto's H-index, a measure of scientific impact, exceeds 100. He is an inventor/co-inventor of several patents, the editor of six books, a member of over 10 editorial boards of international journals, the former editor-in-chief of the International Journal of Pharmacognosy (1990-1995), the former editor-in-chief of Combinatorial Chemistry and High Throughput Screening (1996-1997), and the current editor-in-chief of Pharmaceutical Biology.
He has served on the National Cancer Institute subcommittee on cancer epidemiology, prevention and control, and was the recipient of a Research Career Development Award from the National Cancer Institute (1984-1989) and a Research Fellowship from the Alexander von Humboldt Foundation (1990-1991). He will be transferring major grant funding to Western New England University when he joins the faculty, and continuing research to explore the health benefits of grapes.
He is an author of over 600 publications, including the first report describing the cancer preventive activity of resveratrol, a component of grapes and grape products such as red wine. This single manuscript has been cited over 5,000 times, and resveratrol is now in numerous clinical trials and the subject of over 20,000 manuscripts.
Pezzuto's H-index, a measure of scientific impact, exceeds 100. He is an inventor/co-inventor of several patents, the editor of six books, a member of over 10 editorial boards of international journals, the former editor-in-chief of the International Journal of Pharmacognosy (1990-1995), the former editor-in-chief of Combinatorial Chemistry and High Throughput Screening (1996-1997), and the current editor-in-chief of Pharmaceutical Biology.
He has served on the National Cancer Institute subcommittee on cancer epidemiology, prevention and control, and was the recipient of a Research Career Development Award from the National Cancer Institute (1984-1989) and a Research Fellowship from the Alexander von Humboldt Foundation (1990-1991). He will be transferring major grant funding to Western New England University when he joins the faculty, and continuing research to explore the health benefits of grapes.
Research Interests
Papers共 793 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
crossref(2024)
American Journal of Pharmaceutical Educationno. 7 (2024): 100723-100723
Antioxidants (Basel, Switzerland)no. 10 (2023): 1821-1821
Eun-Jung Park,Tamara P. Kondratyuk,Andrew Morrell, Evgeny Kiselev,Martin Conda-Sheridan,Mark Cushman,Soyoun Ahn,Yongsoo Choi, Jerry J. White,Richard B. van Breemen,John M. Pezzuto
crossref(2023)
Feifei Liu,Timothy J. O'Donnell, Eun-Jung Park, Sasha Kovacs, Kenzo Nakamura,Asim Dave,Yuheng Luo,Rui Sun,Marisa Wall,Supakit Wongwiwatthananukit,Dane Kaohelani Silva, Philip G. Williams,
Scientific Reportsno. 1 (2023): 1-19
M. Heinrich,B. Jalil, M. Abdel-Tawab,J. Echeverria, Z. Kulic,L. J. McGaw,J. M. Pezzuto, O. Potterat,J-B Wang
PLANTA MEDICAno. 15 (2022): 1409-1410
British Journal of Pharmacy (2022)
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn